Cantel Medical Reports Financial Results for its Fourth Quarter Fiscal Year 2020

Medical and Dental well positioned as elective procedures positively rebound - COVID fourth quarter impact on elective procedures less severe than expected - Elective procedures rebounded to approximately 80% - 85% of pre-COVID levels and strengthening - Net sales of $233.4M\, down 2.5% - GAAP diluted EPS of $(0.05)\, down 125.5% - Non-GAAP diluted EPS of $0.24\, down 62.6% - GAAP net loss of $(2.